AQUINOX PHARMACEUTICALS, INC Uncategorized Contracts & Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2024
Contingent Value Rights Agreement, dated December 18, 2023, by and among Neoleukin Therapeutics, Inc., Equiniti Trust Company, LLC and Donna Cochener
AQUINOX PHARMACEUTICALS, INC
Biotechnology
DE
2023
Form of Revised CVR Agreement
AQUINOX PHARMACEUTICALS, INC
Biotechnology
DE
2023
Description of Securities Registered Under Section 12 of the Securities Exchange Act of 1934, as amended
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2020
Form of Lock-Up Agreement, by each of the parties named in each agreement therein
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2019
Form of Support Agreement, by and among Aquinox Pharmaceuticals, Inc., Neoleukin Therapeutics, Inc. and each of the parties named in each agreement therein
AQUINOX PHARMACEUTICALS, INC
Biotechnology
DE
2019
Agreement
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2016
AQUINOX PHARMACEUTICALS, INC. $25,000,000 SALESAGREEMENT
AQUINOX PHARMACEUTICALS, INC
Biotechnology
NY
2015
David Main
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2014
SCHEDULE A AQUINOX PHARMACEUTICALS INC. AQUINOX PHARMACEUTICALS (USA) INC. OPTION AGREEMENT
AQUINOX PHARMACEUTICALS, INC
Biotechnology
2014